This HTML5 document contains 44 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n10http://dx.doi.org/10.1046/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q73189615
rdf:type
wikibase:Item
schema:description
наукова стаття, опублікована у вересні 1999 wetenschappelijk artikel artículu científicu espublizáu en setiembre de 1999 scientific article published on 01 September 1999 im September 1999 veröffentlichter wissenschaftlicher Artikel
p:P577
wds:Q73189615-9F139152-C64F-4B78-89F8-80520E29FAD2
wdt:P577
1999-09-01T00:00:00Z
p:P2093
wds:Q73189615-17E8BEFA-5685-429D-BFCD-862D23A9C4BB wds:Q73189615-00ED19FD-4546-4712-866A-A7DFAA9D41B9 wds:Q73189615-3F77705F-B63A-4847-8413-7CA4989C3F07 wds:Q73189615-BB882D74-7411-4E00-A8E8-F8F1385CB915 wds:Q73189615-F33D74DB-3D4B-475F-9F40-497B61502D9C wds:Q73189615-C5A350C7-25CF-4CB6-AA4E-73B8037BF0FE
wdt:P2093
B H Schwab A R Sampson D L Steed B H Perry T J Wieman J M Smiell
rdfs:label
Efficacy and safety of becaplermin (recombinant human platelet-derived growth factor-BB) in patients with nonhealing, lower extremity diabetic ulcers: a combined analysis of four randomized studies Efficacy and safety of becaplermin (recombinant human platelet-derived growth factor-BB) in patients with nonhealing, lower extremity diabetic ulcers: a combined analysis of four randomized studies
skos:prefLabel
Efficacy and safety of becaplermin (recombinant human platelet-derived growth factor-BB) in patients with nonhealing, lower extremity diabetic ulcers: a combined analysis of four randomized studies Efficacy and safety of becaplermin (recombinant human platelet-derived growth factor-BB) in patients with nonhealing, lower extremity diabetic ulcers: a combined analysis of four randomized studies
schema:name
Efficacy and safety of becaplermin (recombinant human platelet-derived growth factor-BB) in patients with nonhealing, lower extremity diabetic ulcers: a combined analysis of four randomized studies Efficacy and safety of becaplermin (recombinant human platelet-derived growth factor-BB) in patients with nonhealing, lower extremity diabetic ulcers: a combined analysis of four randomized studies
p:P1476
wds:Q73189615-0D52AEA7-124A-4706-86D7-8208911E971B
wdt:P1476
Efficacy and safety of becaplermin (recombinant human platelet-derived growth factor-BB) in patients with nonhealing, lower extremity diabetic ulcers: a combined analysis of four randomized studies
p:P304
wds:Q73189615-E612955D-4B91-4BA1-B3EB-DCF64ADDAF84
wdt:P304
335-346
p:P31
wds:Q73189615-2BFF23CA-CB09-41AF-B4AD-0F2C53DF9C02
wdt:P31
wd:Q13442814
p:P698
wds:Q73189615-A4C43437-5EC3-470B-B212-3D2E35604315
wdtn:P698
n12:10564562
wdt:P698
10564562
p:P1433
wds:Q73189615-B9BC1BE1-ADBD-4700-B1E1-9F92295E26FD
wdt:P1433
wd:Q3538612
p:P433
wds:Q73189615-43284E34-1783-4E7D-ADCD-5B64B29B7116
p:P478
wds:Q73189615-D76D29F1-C7D8-40F7-BC42-1FBB3C5785F3
wdt:P433
5
wdt:P478
7
p:P356
wds:Q73189615-BA168644-42DF-431D-98BD-8C80DD574632
wdtn:P356
n10:J.1524-475X.1999.00335.X
wdt:P356
10.1046/J.1524-475X.1999.00335.X